Mitochondrial respiratory chain dysfunction modulates metalloproteases -1, -3 and -13 in human normal chondrocytes in culture

BMC Musculoskeletal Disorders

Volumn 14, Issue , 2013, Pages

  Cillero Pastor, Berta ^a   Rego Pérez, Ignacio ^a   Oreiro, Natividad ^a   Fernandez Lopez, Carlos ^a   Blanco, Francisco J ^a  

^a UNIVERSITY OF A CORUÑA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROPROPIONIC ACID; ANTIMYCIN A1; COLLAGENASE 3; INTERSTITIAL COLLAGENASE; MESSENGER RNA; MITOCHONDRIAL COMPLEX IV; MITOCHONDRIAL COMPLEX V; OLIGOMYCIN; OXIDOREDUCTASE; PROTEOGLYCAN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); ROTENONE; SODIUM AZIDE; STROMELYSIN; UBIQUINOL CYTOCHROME C REDUCTASE; UNCLASSIFIED DRUG;

ARTICLE; AUTOPSY; CADAVER DONOR; CARTILAGE CELL; CARTILAGE DEGENERATION; CELL ISOLATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KNEE; MITOCHONDRIAL RESPIRATION; NORMAL HUMAN; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RESPIRATORY CHAIN; WESTERN BLOTTING;

ADOLESCENT; ADULT; AGED; CARTILAGE, ARTICULAR; CELLS, CULTURED; CHONDROCYTES; ENZYME INHIBITORS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; METALLOPROTEASES; MIDDLE AGED; MITOCHONDRIA; MITOCHONDRIAL DISEASES; PROTEOGLYCANS; YOUNG ADULT;

EID: 84881187968     PISSN: None     EISSN: 14712474     Source Type: Journal    
DOI: 10.1186/1471-2474-14-235     Document Type: Article

References (50)

1. Joint homeostasis, restoration, and remodeling in osteoarthritis. Lories RJ, Best Pract Res Clin Rheumatol 2008 22 209 20 18455680 (Pubitemid 351606941)
2. Evidence of inflammatory mechanisms in osteoarthritis. Lopez-Armada MJ, Vaamonde-Garcia C, Carames B, Lires-Dean M, Cillero-Pastor B, Blanco Garcia FJ, Reumatol Clin 2007 3 Suppl 3 23 7 21794477
3. Mitochondrial respiratory activity is altered in osteoarthritic human articular chondrocytes. Maneiro E, Martin MA, de Andres MC, Lopez-Armada MJ, Fernandez-Sueiro JL, et al. Arthritis Rheum 2003 48 700 8 10.1002/art.10837 12632423 (Pubitemid 36302006)
4. Mitochondrial dysfunction in osteoarthritis. Blanco FJ, Lopez-Armada MJ, Maneiro E, Mitochondrion 2004 4 715 28 10.1016/j.mito.2004.07.022 16120427 (Pubitemid 39646817)
5. Role of European mitochondrial DNA haplogroups in the prevalence of hip osteoarthritis in Galicia, Northern Spain. Rego I, Fernandez-Moreno M, Fernandez-Lopez C, Gomez-Reino JJ, Gonzalez A, et al. Ann Rheum Dis 2010 69 210 3 10.1136/ard.2008.105254 19224903
6. Mitochondrial activity is modulated by TNFalpha and IL-1beta in normal human chondrocyte cells. Lopez-Armada MJ, Carames B, Martin MA, Cillero-Pastor B, Lires-Dean M, et al. Osteoarthritis Cartilage 2006 14 1011 22 10.1016/j.joca.2006.03.008 16679036 (Pubitemid 44321373)
7. Osteoarthritis and nitric oxide. Abramson SB, Osteoarthritis Cartilage 2008 16 Suppl 2 15 20 18794013
8. Nitric oxide in inflammation and pain associated with osteoarthritis. Abramson SB, Arthritis Res Ther 2008 10 Suppl 2 2 10.1186/ar2463 19007427
9. Effect of nitric oxide on mitochondrial respiratory activity of human articular chondrocytes. Maneiro E, Lopez-Armada MJ, de Andres MC, Carames B, Martin MA, et al. Ann Rheum Dis 2005 64 388 95 15708893 (Pubitemid 40283048)
10. The complex pathology of osteoarthritis: even mitochondria are involved. Roach HI, Arthritis Rheum 2008 58 2217 8 10.1002/art.23635 18668573
11. Effect of nitric oxide on mitochondrial activity of human synovial cells. Cillero-Pastor B, Martin MA, Arenas J, Lopez-Armada MJ, Blanco FJ, BMC Musculoskelet Disord 2011 12 42 10.1186/1471-2474-12-42 21303534
12. Dimethylarginine dimethylaminohydrolase 2, a newly identified mitochondrial protein modulating nitric oxide synthesis in normal human chondrocytes. Cillero-Pastor B, Mateos J, Fernandez-Lopez C, Oreiro N, Ruiz-Romero C, Blanco FJ, Arthritis Rheum 2012 64 204 12 10.1002/art.30652 21898353
13. Mitochondrial dysfunction activates cyclooxygenase 2 expression in cultured normal human chondrocytes. Cillero-Pastor B, Carames B, Lires-Dean M, Vaamonde-Garcia C, Blanco FJ, Lopez-Armada MJ, Arthritis Rheum 2008 58 2409 19 10.1002/art.23644 18668543
14. Mechanism of cartilage destruction in osteoarthritis. Ishiguro N, Kojima T, Poole AR, Nagoya J Med Sci 2002 65 73 84 12580533
15. Regulation of matrix metalloproteinases: an overview. Chakraborti S, Mandal M, Das S, Mandal A, Chakraborti T, Mol Cell Biochem 2003 253 269 85 10.1023/A:1026028303196 14619979 (Pubitemid 37321735)
16. Matrix metalloproteinases in arthritic disease. Murphy G, Knauper V, Atkinson S, Butler G, English W, et al. Arthritis Res Therap 2002 4 Suppl 3 39 49 10.1186/ar572
17. Localization of matrix metalloproteinase 3 (stromelysin) in osteoarthritic cartilage and synovium. Okada Y, Shinmei M, Tanaka O, Naka K, Kimura A, et al. Lab Invest 1992 66 680 90 1602738
18. Levels of metalloproteinase (MMP-3, MMP-9), NF-kappaB ligand (RANKL), and nitric oxide (NO) in peripheral blood of osteoarthritis (OA) patients. Li H, Li L, Min J, Yang H, Xu X, Yuan Y, Wang D, Clin Lab 2012 58 755 762 22997976
19. [A study of serum cartilage oligomeric matrix protein and matrix metalloproteinase-3 concentration in osteoarthritic rabbit models]. Li GY, Zhang RF, Pan L, Zhang X, Zhang K, Wang GC, Wu DH, Ma L, Zhonghua Nei Ke Za Zhi 2011 50 416 419 21624227
20. Effect of chondroitin sulfate and hyaluronic acid (500-730 kDa) on synthesis of stromelysin (MMP-3) and MMP-1 in human chondrocyte cultures]. Monfort J, Nacher M, Montell E, Tomas E, Verges J, Benito P, Reumatol Clin 2005 1 150 154 10.1016/S1699-258X(05)72734-0 21794254
21. Chondroitin sulfate and hyaluronic acid (500-730 kda) inhibit stromelysin-1 synthesis in human osteoarthritic chondrocytes. Monfort J, Nacher M, Montell E, Vila J, Verges J, Benito P, Drugs Exp Clin Res 2005 31 71 6 15929608 (Pubitemid 350056458)
22. Biochemical effects of two different hyaluronic acid products in a co-culture model of osteoarthritis. Greenberg DD, Stoker A, Kane S, Cockrell M, Cook JL, Osteoarthritis Cartilage 2006 14 814 822 10.1016/j.joca.2006.02.006 16617026 (Pubitemid 43986363)
23. Mitochondria and apoptosis. Green DR, Reed JC, Science 1998 281 1309 12 9721092 (Pubitemid 28406816)
24. Mitochondrial regulation of apoptotic cell death. Orrenius S, Toxicol Lett 2004 149 19 23 10.1016/j.toxlet.2003.12.017 15093244 (Pubitemid 38469816)
25. Potential involvement of oxidative stress in cartilage senescence and development of osteoarthritis: oxidative stress induces chondrocyte telomere instability and downregulation of chondrocyte function. Yudoh K, Nguyen T, Nakamura H, Hongo-Masuko K, Kato T, Nishioka K, Arthritis Res Ther 2005 7 380 91 10.1186/ar1499 15743486
26. Oxidative stress, mitochondrial DNA mutation, and apoptosis in aging. Lee HC, Wei YH, Exp Biol Med (Maywood) 2007 232 592 606
27. Decreased levels of complex III core protein 1 and complex V beta chain in brains from patients with Alzheimer's disease and Down syndrome. Kim SH, Vlkolinsky R, Cairns N, Lubec G, Cell Mol Life Sci 2000 57 1810 6 10.1007/PL00000661 11130185
28. Mitochondrial dysfunction in the limelight of Parkinson's disease pathogenesis. Banerjee R, Starkov AA, Beal MF, Thomas B, Biochim Biophys Acta 2009 1792 651 63 10.1016/j.bbadis.2008.11.007 19059336
29. Mechanism of toxicity in rotenone models of Parkinson's disease. Sherer TB, Betarbet R, Testa CM, Seo BB, Richardson JR, et al. J Neurosci 2003 23 10756 64 14645467 (Pubitemid 37499681)
30. Oxidative stress rather than triglyceride accumulation is a determinant of mitochondrial dysfunction in in vitro models of hepatic cellular steatosis. Lockman KA, Baren JP, Pemberton CJ, Baghdadi H, Burgess KE, et al. Liver Int 2012 32 1079 92 10.1111/j.1478-3231.2012.02775.x 22429485
31. Targeting mitochondrial dysfunction and neurodegeneration by means of coenzyme Q10 and its analogues. Orsucci D, Mancuso M, Ienco EC, LoGerfo A, Siciliano G, Curr Med Chem 2011 18 4053 64 10.2174/092986711796957257 21824087
32. Cell death of chondrocytes is a combination between apoptosis and autophagy during the pathogenesis of Osteoarthritis within an experimental model. Almonte-Becerril M, Navarro-Garcia F, Gonzalez-Robles A, Vega-Lopez MA, Lavalle C, Kouri JB, Apoptosis 2010 15 631 8 10.1007/s10495-010-0458-z 20091349
33. The structure, physiology, and biomechanics of articular cartilage: injury and repair. Tatari H, Acta Orthop Traumatol Turc 2007 41 Suppl 2 1 5 18180577
34. Mediation of spontaneous knee osteoarthritis by progressive chondrocyte ATP depletion in Hartley guinea pigs. Johnson K, Svensson CI, Etten DV, Ghosh SS, Murphy AN, et al. Arthritis Rheum 2004 50 1216 25 10.1002/art.20149 15077304 (Pubitemid 38480832)
35. Invited review: the mitochondrion in osteoarthritis. Terkeltaub R, Johnson K, Murphy A, Ghosh S, Mitochondrion 2002 1 301 19 10.1016/S1567-7249(01) 00037-X 16120285 (Pubitemid 34272620)
36. Factors influencing the oxygen concentration gradient from the synovial surface of articular cartilage to the cartilage-bone interface: a modeling study. Zhou S, Cui Z, Urban JP, Arthritis Rheum 2004 50 3915 24 10.1002/art.20675 15593204 (Pubitemid 39643939)
37. Mitochondrial dysregulation of osteoarthritic human articular chondrocytes analyzed by proteomics: a decrease in mitochondrial superoxide dismutase points to a redox imbalance. Ruiz-Romero C, Calamia V, Mateos J, Carreira V, Martinez-Gomariz M, et al. Mol Cell Proteomics 2009 8 172 89 10.1074/mcp.M800292-MCP200 18784066
38. Differential effects of tumor necrosis factor-alpha and interleukin-1beta on cell death in human articular chondrocytes. Carames B, Lopez-Armada MJ, Cillero-Pastor B, Lires-Dean M, Vaamonde C, et al. Osteoarthritis Cartilage 2008 16 715 22 10.1016/j.joca.2007.10.006 18054255 (Pubitemid 351753713)
39. Peroxynitrite mediates calcium-dependent mitochondrial dysfunction and cell death via activation of calpains. Whiteman M, Armstrong JS, Cheung NS, Siau JL, Rose P, et al. FASEB J 2004 18 1395 7 15240564 (Pubitemid 39561592)
40. Apoptotic insults to human chondrocytes induced by sodium nitroprusside are involved in sequential events, including cytoskeletal remodeling, phosphorylation of mitogen-activated protein kinase kinase kinase-1/c-Jun N-terminal kinase, and Bax-mitochondria-mediated caspase activation. Cherng YG, Chang HC, Lin YL, Kuo ML, Chiu WT, Chen RM, J Orthop Res 2008 26 1018 26 10.1002/jor.20578 18306405
41. Inhibition of complex III promotes loss of Ca2+ dependence for mitochondrial superoxide formation and permeability transition evoked by peroxynitrite. Guidarelli A, Cerioni L, Cantoni O, J Cell Sci 2007 120 1908 14 10.1242/jcs.003228 17504811 (Pubitemid 46979782)
42. The effect of O2 tension on pH homeostasis in equine articular chondrocytes. Milner PI, Fairfax TP, Browning JA, Wilkins RJ, Gibson JS, Arthritis Rheum 2006 54 3523 32 10.1002/art.22209 17075856 (Pubitemid 44737164)
43. Shaping the role of mitochondria in the pathogenesis of Huntington's disease. Costa V, Scorrano L, EMBO J 2012 31 1853 64 10.1038/emboj.2012.65 22446390
44. The role of mitochondria in the pathogenesis of Huntington's disease. Karachitos A, Galganska H, Kmita H, Postepy Biochem 2010 56 174 81 20873112
45. Mitochondrial oxidative phosphorylation is a downstream regulator of nitric oxide effects on chondrocyte matrix synthesis and mineralization. Johnson K, Jung A, Murphy A, Andreyev A, Dykens J, Terkeltaub R, Arthritis Rheum 2000 43 1560 70 10.1002/1529-0131(200007)43:7<1560::AID-ANR21>3.0.CO;2-S 10902761 (Pubitemid 30452477)
46. Gene expression of matrix metalloproteinases 1, 3, and 9 by chondrocytes in osteoarthritic human knee articular cartilage is zone and grade specific. Freemont AJ, Hampson V, Tilman R, Goupille P, Taiwo Y, Hoyland JA, Ann Rheum Dis 1997 56 542 549 10.1136/ard.56.9.542 9370879 (Pubitemid 27428477)
47. Differential regulation of cytokine-induced MMP-1 and MMP-13 expression by p38 kinase inhibitors in human chondrosarcoma cells: potential role of Runx2 in mediating p38 effects. Pei Y, Harvey A, Yu XP, Chandrasekhar S, Thirunavukkarasu K, Osteoarthritis Cartilage 2006 14 749 58 10.1016/j.joca.2006. 01.017 16549373 (Pubitemid 43986358)
48. Mitochondrial redox control of matrix metalloproteinase signaling in resistance arteries. Touyz RM, Arterioscler Thromb Vasc Biol 2006 26 685 8 10.1161/01.ATV.0000216428.90962.60 16556862 (Pubitemid 43732138)
49. Mitochondrial redox control of matrix metalloproteinases. Nelson KK, Melendez JA, Free Radic Biol Med 2004 37 768 84 10.1016/j.freeradbiomed.2004.06. 008 15304253 (Pubitemid 39078549)
50. Angiotensin II, mitochondria, cytoskeletal, and extracellular matrix connections: an integrating viewpoint. de Cavanagh EM, Ferder M, Inserra F, Ferder L, Am J Physiol Heart Circ Physiol 2009 296 550 8 10.1152/ajpheart.01176. 2008 19151249